Tally Health acquired by Infinite Epigenetics
Infinite Epigenetics acquired Tally Health, a diagnostics brand, on Apr 29, 2026.
Preliminary: The deal status is not yet independently verified.
Transaction summary
- Target
- Tally Health
- Acquirer
- Infinite Epigenetics
- Seller
- -
- Announced
- 2026-04-29
- Completed
- 2026-04-29
- Geography
- -
- Type
- Acquisition
- Deal type
- Control
- Stake acquired
- -
- First added
- 2026-08-03
- Latest update
- 2026-11-03
Value and multiples
100% enterprise value
Undisclosed
Value not disclosed
Basis: FundComb estimate
Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.
EV / revenue
-
Period not stated
Basis: FundComb estimate
EV / EBITDA
-
EBITDA basis not stated
Basis: FundComb estimate
Basis
- Enterprise value is unavailable.
Source summary
Infinite Epigenetics acquires Tally Health
ConfirmedFitt Insider reported on April 30, 2026 that Infinite Epigenetics acquired Tally Health, combining epigenetic testing and data capabilities with Tally Health's consumer longevity offerings.
Open sourceContinue your research
Related transaction comps
Twinlab acquired by cbdMD
2026-09-02 · Confirmed
View transaction → SupplementsJamieson Wellness acquired by Kirin Holdings Company
2026-08-06 · Confirmed
View transaction → SupplementsThorne acquired by Procter & Gamble
2026-08-04 · Estimated
View transaction → SupplementsImaraïs Beauty acquired by Healthy Extracts
2026-05-18 · Confirmed
View transaction →